Using quantitative RT-PCR in the BCR-ABL1+ cells (K562, CML-T1, and LAMA84), we verified the decreased expression of RMND1 with approximately 30%, 23%, and 27% compared to control, respectively. This evidence concerns the gene ABL1 and chronic myelogenous leukemia, BCR-ABL1 positive.